DesmopressinThird Party Manufacturing in India

Desmopressin works by acting as a highly selective agonist at the vasopressin V2 receptors located in the basolateral membrane of the collecting ducts in the kidneys. This binding stimulates adenylate cyclase, causing the insertion of aquaporin-2 water channels into the apical membrane, increasing water permeability and reabsorption. Unlike natural vasopressin, it displays minimal pressor activity at V1 receptors, ensuring it does not alter systemic blood pressure significantly during routine administration. It is highly effective and well-tolerated when given via the nasal mucosa for rapid absorption. Sourcing Desmopressin third party manufacturing in India helps brands secure a complex peptide formulation within their specialty therapeutic categories. The compound is officially verified with CAS number 16679-58-6.

Therapeutic Uses

• Central Diabetes Insipidus: Replaces endogenous antidiuretic hormone to manage polyuria and polydipsia.
• Primary Nocturnal Enuresis: Helps control bedwetting in pediatric and adult patient demographics by reducing night urine volume.

Why Manufacturers Choose Desmopressin

Celesta Healthcare provides access to elite peptide processing laboratories across India. Our partner facilities are WHO-GMP certified, maintaining strict environmental controls to preserve sensitive peptide structures throughout the sterile aqueous filling stage. Selecting a Desmopressin third party manufacturer in India ensures absolute chemical purity and dependable market supply.